ONCO — Onconetix, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1782107 ·
Last close
$3.00
Market Cap
$13.14M
52W High
$1610.00
52W Low
$2.76
ADV30
446,295
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 17,120 4,303 -2,244,790 -2,867,303 16,426,341 5,942,249 2,956,108
Mar 2026 21,457 -1,655 -2,091,801 -4,214,875 14,832,086 3,716,072 3,083,885
Dec 2025 303,596 247,684 -1,281,367 5,669,687 24,926,638 5,220,654 9,160,287
Sep 2025 303,651 268,894 -2,069,242 -8,783,702 19,678,868 836,556 16,303,023

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-10,307,962
Investing CF
$0
Financing CF
$15,638,021
CapEx
—
Dividends Paid
—
Buybacks
$-348
EPS Diluted TTM
$-618.79
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-138,296,736
Inventory
$210,448
Receivables
$48,740
ST Investments
—
EBIT TTM
$-9,884,719
Pretax Income TTM
$-10,195,668
Interest Exp TTM
$310,949
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$645,824
EBITDA
$-7,672,447
Free Cash Flow
$-5,920,061
Enterprise Value
$-2,768,016
Total Cash
$5,942,249
Total Debt
$187,128
Shares Out
4,380,522
Trailing EPS
$749.08
Book Value
$3.55
ROE
-105.2%
ROA
-27.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 815,371 -6,344,856 -14,032,342 24,926,638 9,160,287 15,766,351 -9,678,390
Dec 2024 2,524,116 -10,331,243 -58,691,023 28,181,563 18,571,008 9,610,555 -10,495,816
Dec 2023 58,465 -17,847,249 -37,409,694 87,518,032 86,113,556 -5,602,028 -13,581,018
Dec 2022 0 -13,481,240 -13,419,830 26,310,447 3,922,445 22,388,002 -8,675,534
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$645,824
NetIncome TTM
$-10,196,193
OpCashFlow TTM
—
Assets (Latest)
$16,426,341
Forward EPS
$-0.85

Peers — same industry

TickerNameMarket CapLastDaily %
AKTX Akari Therapeutics Plc $13.03M $5.70 —
ALLR Allarity Therapeutics, Inc. $13.38M $0.84 —
TVRD Tvardi Therapeutics, Inc. $13.47M $1.01 —
SYBX SYNLOGIC, INC. $13.47M $1.10 —
MTNB Matinas BioPharma Holdings, Inc. $12.57M $0.86 —

News headlines (Yahoo Finance, 1h cache)

Realbotix Provides Update on Nasdaq Listing Timeline
2026-11-09 15:24 · Yahoo
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
2026-10-27 12:30 · Yahoo
Onconetix Announces Reverse Stock Split
2026-10-26 21:03 · Yahoo
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
2026-10-23 12:30 · Yahoo
Realbotix Announces Additional Draw under Bridge Loan from Onconetix
2026-10-23 11:30 · Yahoo
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
2026-09-24 16:30 · Yahoo
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
2026-09-14 12:30 · Yahoo
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
2026-09-03 12:30 · Yahoo
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
2026-08-06 12:30 · Yahoo
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
2026-07-07 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.